4//SEC Filing
Papapetropoulos Spyridon 4
Accession 0000899243-22-009052
CIK 0001827087other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:05 PM ET
Size
5.6 KB
Accession
0000899243-22-009052
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Chief Medical Officer
Transactions
- Award
Stock Option Grant (Right to Buy)
2022-03-01+75,500→ 75,500 totalExercise: $16.13Exp: 2032-03-01→ Common Stock (75,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2022.
Documents
Issuer
Vigil Neuroscience, Inc.
CIK 0001827087
Entity typeother
Related Parties
1- filerCIK 0001832694
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:05 PM ET
- Size
- 5.6 KB